Tech Company Financing Transactions
Formation Bio Funding Round
Andreessen Horowitz, Owkin and Sanofi Ventures participated in a $372 million Series D capital raise for Formation Bio. The round was announced on 6/26/2024.
Transaction Overview
Company Name
Announced On
6/26/2024
Transaction Type
Venture Equity
Amount
$372,000,000
Round
Series D
Investors
Proceeds Purpose
Formation plans to deploy this capital to continue to acquire and in-license clinical-stage assets from its biotech and pharma partners.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
16 East 34th Street Floor 10
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Undisclosed
Website
Email Address
Overview
Despite tech advancements, bringing a new drug to market remains a decade-long, billion-dollar endeavor. The time and costs of drug development continue to climb, leading to higher drug and healthcare costs, and making treatments less accessible for many. By taking a radically more efficient approach across the drug development lifecycle, we are moving faster than ever before toward bringing treatments to patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ben Liu
Chief Financial Officer
James Leslie
Chief Technical Officer
Linhao Zhang
VP - Bus. Development
Gavin Corcoran
VP - Human Resources
Melissa Enbar
Browse more venture capital transactions:
Prev: 6/26/2024: Form Health venture capital transaction
Next: 6/26/2024: Fetcherr venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs